Acne

Fixed-dose clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% gel demonstrated safety and efficacy across all age groups for the treatment of acne, according to a post hoc analysis.

Dapsone gel 7.5% demonstrated safety, tolerability and efficacy for the treatment of acne vulgaris in patients with skin of color, according to a study.

Atrophic acne scars are difficult to treat, but a new study found that combination therapy with microneedling and 60% phenol and 0.2% croton oil was an effective and safe treatment option.

Isotretinoin is generally effective and well tolerated for acne treatment in patients receiving masculinizing gender-affirming care, but barriers can impede treatment success, according to a study.

Rehmannia glutinosa leaf extract supplementation improved acne severity, skin hydration and the quality of life of women with acne vulgaris, according to a study.

Healio has compiled May’s most-read news in dermatology.

Trifarotene cream 0.005%, in conjunction with a proper skincare regimen, reduced acne lesions and acne-induced hyperpigmentation within 24 weeks, according to study.

High adherence to an antioxidant diet reduced the risk for acne impacting patient quality of life in women, according to a study.

Researchers identified five barriers to proper antibiotic stewardship in acne treatment and recommended the implementation of an antibiotic stewardship program, according to a study.

Topical triple-agent fixed-dose combination gel outperformed other treatment options for moderate to severe acne, according to a study.